IBM Micromedex Pediatrics
7.3 5
v4.6.0 by Mobile Micromedex
關於 IBM Pediatrics
IBM Pediatrics（包名：com.thomson.pediatrics）開發者是Mobile Micromedex，IBM Pediatrics的最新版本4.6.0更新時間為2022年10月30日。IBM Micromedex Pediatrics的分類是醫療。您可以查看IBM Micromedex Pediatrics的開發者下的所有應用並找到IBM Micromedex Pediatrics在安卓上的200個相似應用。目前這個應用免費。該應用可以從APKFab或Google Play下載到Android 4.4+。APKFab.com的所有APK/XAPK文檔都是原始文檔並且100%安全下載的資源。
IBM Micromedex Pediatrics is free to online subscribers of Micromedex Standard Pediatric Drug Information online.
IBM Micromedex Pediatrics is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for pediatric patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This pediatric-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
IBM Micromedex® is a trusted source for pediatric drug dosing, based on the strict editorial policies and practices that have guided Micromedex for more than 30 years. Evidence-based, fully referenced pediatric-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 100 different infant formulas and human milk fortifiers, and pediatric prescription enteral formulas.
IBM Micromedex Pediatrics drug information is intended for full-term babies 29 days of age and older (postnatal age) and preterm babies over 44 weeks postmenstrual age, up to 18 years of age.
Do you work at a facility that subscribes to IBM Micromedex Pediatrics? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the PICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to IBM Micromedex Pediatrics Online, FREE access to these apps requires a password. To obtain the Pediatrics password contact support at:
https://www.ibm.com/support/home/pages/support-guide/?product=4592217
Existing paid customers will continue to have access to the content going forward.
IBM Micromedex Pediatrics is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for pediatric patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This pediatric-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
IBM Micromedex® is a trusted source for pediatric drug dosing, based on the strict editorial policies and practices that have guided Micromedex for more than 30 years. Evidence-based, fully referenced pediatric-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 100 different infant formulas and human milk fortifiers, and pediatric prescription enteral formulas.
IBM Micromedex Pediatrics drug information is intended for full-term babies 29 days of age and older (postnatal age) and preterm babies over 44 weeks postmenstrual age, up to 18 years of age.
Do you work at a facility that subscribes to IBM Micromedex Pediatrics? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the PICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to IBM Micromedex Pediatrics Online, FREE access to these apps requires a password. To obtain the Pediatrics password contact support at:
https://www.ibm.com/support/home/pages/support-guide/?product=4592217
Existing paid customers will continue to have access to the content going forward.
IBM Pediatrics 4.6.0 更新
• Updates in preparation for the sunsetting of the app. For more information, email our team with questions at: ProductSupport@Merative.com
查看更多
IBM Pediatrics 資訊
歷史版本
更多
Requires Android: Android 4.4+
Architecture: arm64-v8a, armeabi-v7a, x86, x86_64
Screen DPI: 120-640dpi
SHA1: 662b0e7473974776d324018ecc5be1d06343c9ee
Size: 13 MB
What's New:
• Updates in preparation for the sunsetting of the app. For more information, email our team with questions at: ProductSupport@Merative.com
Requires Android: Android 4.4+
Architecture: arm64-v8a, armeabi-v7a, x86, x86_64
Screen DPI: 120-640dpi
SHA1: 60ada2c986825369410a87f78f2e46593cd78c2b
Size: 12.98 MB
What's New:
• Bug fixes
Requires Android: Android 4.4+
Architecture: arm64-v8a, armeabi-v7a, x86, x86_64
Screen DPI: 120-640dpi
SHA1: 9493eeace83d16c92106da1521cdcfab0c155432
Size: 13 MB
What's New:
• Addition of a new support email address to reflect the new branding.
• Bug fixes
• Bug fixes
Requires Android: Android 4.4+
Architecture: arm64-v8a, armeabi-v7a, x86, x86_64
Screen DPI: 120-640dpi
SHA1: c0173f88b672466f8af217f0c9a3c6f8f8f2bd09
Size: 13 MB
What's New:
• Security updates
更多資訊
更新日期:
2022-10-30
最新版本:
4.6.0
請求更新:
系統要求:
Android 4.4+
舉報:
安全下載
APKFab.com和該應用的下載連結是100%安全的。APKFab.com上列出的所有應用下載連結均來自Google Play Store或由用戶提交。對於來自Google Play商店的應用，APKFab.com不會對其進行任何形式的修改。對於用戶提交的應用，APKFab.com會在網站上發佈之前驗證其APK簽名的安全性。